The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity

ConditionChronic Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-65
SponsorUniversity of Tartu

About this trial

The goal of this clinical trial is to learn if pain knowledge group intervention among chronic pain patients would influence their level of physical activity, pain intensity, depression, kinesiophobia and central sensitization. The main question it aims to answer is:

Primary hypothesis: pain education will decrease participants' depression and pain intensity and increase their physical activity.

There is no comparison group.

Participants will participate in a 6-week pain knowledge intervention where they will be learning about sleep, stress models, physical activity benefits, pain neurobiology, mindfulness, pain medication.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pain lasting longer than 3 months,

Consequences resulting from long-term pain (such as decreased physical activity, sleep disturbances, fatigue, low mood, etc.)

Disqualifiers

Surgery that occurred less than 3 months prior

Fracture or limb trauma that occurred less than 3 months prior

Trial design

Design model

Single group

Treatments tested in this trial

  • pain education

    Behavioral

    In one group there will be 8-12 participants who will meet once a week during 6 -weeks time. The educational sessions will be 2-hours long including sometimes some exercises and also reflection of the participants.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Pain education interventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change of pain intensity from baseline to 6-weeks

Pain is measured using Graded Chronic Pain Scale -Revised where the lowest value is 0 and the highest is 100. The higher the score, the more pain the subject feels.

Time frame
from enrollment to the end of treatment at 6 weeks
2

Change of pain intensity from baseline to 6-weeks

Pain is measured using Brief Pain Inventory Short form where the lowest value is 0 and the highest value is 10. The higher the score, the more pain the subject feels.

Time frame
from enrollment to the end of treatment at 6 weeks

Secondary outcomes

1

Change in depression from baseline to 6-weeks

Depression is measured using Emotional well-being questionnaire where the lowest value is 0 and the highest value is 100. Lower score indicates worse health condition.

Time frame
from enrollment to the end of treatment at 6 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.